检索结果 - Zhi‐Cheng Jing

Refine Results
  1. 1
    Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak

    Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak 由 Zhi‐Cheng Jing, Hua-Dong Zhu, Xiaowei Yan, Wen-Zhao Chai, Shuyang Zhang

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Experimental animal models of pulmonary hypertension: Development and challenges

    Experimental animal models of pulmonary hypertension: Development and challenges 由 Xiaohan Wu, Jie‐Ling Ma, Dong Ding, Yuejiao Ma, Yunpeng Wei, Zhi‐Cheng Jing

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Burnout and Well-Being Among Medical Professionals in China: A National Cross-Sectional Study

    Burnout and Well-Being Among Medical Professionals in China: A National Cross-Sectional Study 由 Ying Xiao, Dong Dong, Huanyu Zhang, Peipei Chen, Xiangyan Li, Zhuang Tian, Zhi‐Cheng Jing, Shuyang Zhang

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Protein O-GlcNAcylation in cardiovascular diseases

    Protein O-GlcNAcylation in cardiovascular diseases 由 Hui‐Fang Wang, Yixuan Wang, Yu‐Ping Zhou, Yunpeng Wei, Yi Yan, Zejian Zhang, Zhi‐Cheng Jing

    出版 2022
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Oestradiol ameliorates monocrotaline pulmonary hypertension<i>via</i>NO, prostacyclin and endothelin-1 pathways

    Oestradiol ameliorates monocrotaline pulmonary hypertension<i>via</i>NO, prostacyclin and endothelin-1 pathways 由 Ping Yuan, Wenhui Wu, Lan Gao, Zeqi Zheng, Dong Liu, Han-Ying Mei, Zhuoli Zhang, Zhi‐Cheng Jing

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension

    The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension 由 Youfei Fan, Rui Zhang, Xin Jiang, Li Wen, Danchen Wu, Dong Liu, Ping Yuan, Yulin Wang, Zhi‐Cheng Jing

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Publisher Correction: Pulmonary hypertension

    Publisher Correction: Pulmonary hypertension 由 Ana Olga Mocumbi, Marc Humbert, Anitá Saxena, Zhi‐Cheng Jing, Karen Sliwa, Friedrich Thienemann, Stephen L. Archer, Simon Stewart

    出版 2024
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Treatment algorithm for pulmonary arterial hypertension

    Treatment algorithm for pulmonary arterial hypertension 由 Kelly Chin, Seán Gaine, Christian Gerges, Zhi‐Cheng Jing, Stephen C. Mathai, Yuichi Tamura, Vallerie V. McLaughlin, Olivier Sitbon

    出版 2024
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  9. 9
    Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension

    Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension 由 Rong Jiang, Zisheng Ai, Xin Jiang, Ping Yuan, Dong Liu, Qin‐Hua Zhao, Jing He, Lan Wang, Mardi Gomberg‐Maitland, Zhi‐Cheng Jing

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients

    Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients 由 Yanjie Hao, Xin Jiang, Wei Zhou, Yong Wang, Lan Gao, Yu Wang, Guangtao Li, Hong Tao, Yong Huo, Zhi‐Cheng Jing, Zhuoli Zhang

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension

    Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension 由 Yuan Huang, Yiwei Liu, Haizhou Pan, Xiaoling Zhang, Jun Li, Xiang Li, Jian Meng, Peihe Wang, Jun Yang, Zhi‐Cheng Jing, Hao Zhang

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension

    Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension 由 Danchen Wu, C. Conover Talbot, Qun Liu, Zhi‐Cheng Jing, Rachel L. Damico, Rubin M. Tuder, Kathleen C. Barnes, Paul M. Hassoun, Li Gao

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension

    Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension 由 Zhi‐Cheng Jing, Xiaolu Jiang, Z-Y. Han, X-Q. Xu, Y. Wang, Yan Wu, H. Lv, C-R. Ma, YJ Yang, J-L. Pu

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Clinical features of paediatric pulmonary hypertension: a registry study

    Clinical features of paediatric pulmonary hypertension: a registry study 由 Rolf M.F. Berger, Maurice Beghetti, Tilman Humpl, Gary E. Raskob, D. Dunbar Ivy, Zhi‐Cheng Jing, Damien Bonnet, Ingram Schulze‐Neick, Robyn J. Barst

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)

    Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2) 由 Lewis J. Rubin, Nazzareno Galiè, Friedrich Grimminger, Ekkehard Grünig, Marc Humbert, Zhi‐Cheng Jing, Anne Keogh, David Langleben, Arno Fritsch, Flavia Menezes, Neil Davie, Hossein Ardeschir Ghofrani

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Long-term Riociguat Treatment in PAH Patients in WHO Functional Class (FC) I/II Versus FC III/IV at Baseline: Results From the 12-Week Phase III PATENT-1 Study and PATENT-2 Open-Label Extension

    Long-term Riociguat Treatment in PAH Patients in WHO Functional Class (FC) I/II Versus FC III/IV at Baseline: Results From the 12-Week Phase III PATENT-1 Study and PATENT-2 Open-La... 由 Gisela Meyer, Nazzareno Galiè, Friedrich Grimminger, Ekkehard Grünig, Marc Humbert, Zhi‐Cheng Jing, Anne Keogh, David Langleben, Lewis J. Rubin, Arno Fritsch, Neil Davie, Hossein Ardeschir Ghofrani

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Pulmonary function testing in patients with pulmonary arterial hypertension

    Pulmonary function testing in patients with pulmonary arterial hypertension 由 Zhi‐Cheng Jing, Xi‐Qi Xu, David B. Badesch, Xin Jiang, Yan Wu, Jinming Liu, Yong Wang, Lei Pan, Huiping Li, Jielin Pu, Zhuoli Zhang, Yuejin Yang

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Lower Socioeconomic Status Is Associated with Worse Outcomes in Pulmonary Arterial Hypertension

    Lower Socioeconomic Status Is Associated with Worse Outcomes in Pulmonary Arterial Hypertension 由 Wenhui Wu, Lu Yang, Fu-Hua Peng, Jing Yao, Liling Zou, Dong Liu, Xin Jiang, Jue Li, Lan Gao, Jieming Qu, Steven M. Kawut, Zhi‐Cheng Jing

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Riociguat for the Treatment of Pulmonary Arterial Hypertension

    Riociguat for the Treatment of Pulmonary Arterial Hypertension 由 Hossein Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger, Ekkehard Grünig, Marc Humbert, Zhi‐Cheng Jing, Anne Keogh, David Langleben, Michael Ochan Kilama, Arno Fritsch, D. Neuser, Lewis J. Rubin

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions

    Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions 由 Babar Hasan, Georg Hansmann, Werner Budts, Alexandra Heath, Zahra Hoodbhoy, Zhi‐Cheng Jing, Martin Köestenberger, Katharina Meinel, Ana Olga Mocumbi, G. Radchenko, Hannes Sallmon, Karen Sliwa, Raman Kumar

    出版 2020
    获取全文
    Revisão
    加到收藏夹
    Saved in:

检索工具: